Key regions: Germany, Japan, Netherlands, Spain, United States
The Diagnostic Imaging Devices market in EU-27 is experiencing significant growth due to customer preferences for advanced medical technologies, increasing healthcare expenditure, and the rising prevalence of chronic diseases. Customer preferences in the Diagnostic Imaging Devices market in EU-27 are shifting towards more advanced and innovative technologies. Patients and healthcare professionals are increasingly demanding high-quality imaging devices that provide accurate and detailed diagnostic information. This is driving the market towards the adoption of advanced imaging modalities such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound. Additionally, there is a growing demand for portable and handheld imaging devices that offer convenience and flexibility in point-of-care settings. Trends in the market include the increasing adoption of digital imaging technologies and the integration of artificial intelligence (AI) in diagnostic imaging devices. Digital imaging technologies, such as digital X-ray and digital mammography, offer improved image quality, faster processing times, and the ability to store and share images electronically. AI is being used to enhance the accuracy and efficiency of diagnostic imaging by automating image analysis, identifying abnormalities, and assisting radiologists in making more accurate diagnoses. These trends are driving the growth of the Diagnostic Imaging Devices market in EU-27. Local special circumstances in the EU-27 region include the presence of a well-established healthcare infrastructure, favorable reimbursement policies, and a growing elderly population. The EU-27 region has a highly developed healthcare system with a strong focus on providing high-quality care to its citizens. This creates a conducive environment for the adoption of advanced medical technologies, including diagnostic imaging devices. Additionally, favorable reimbursement policies in many EU-27 countries support the utilization of diagnostic imaging devices by providing financial coverage for patients. The growing elderly population in the EU-27 region is also driving the demand for diagnostic imaging devices, as the elderly are more prone to chronic diseases that require regular monitoring and diagnostic imaging. Underlying macroeconomic factors contributing to the growth of the Diagnostic Imaging Devices market in EU-27 include increasing healthcare expenditure and the rising prevalence of chronic diseases. EU-27 countries have been increasing their healthcare expenditure to improve the accessibility and quality of healthcare services. This increased funding allows healthcare facilities to invest in advanced medical technologies, including diagnostic imaging devices. Furthermore, the rising prevalence of chronic diseases such as cardiovascular diseases, cancer, and musculoskeletal disorders is driving the demand for diagnostic imaging devices. These conditions often require regular imaging for diagnosis, treatment planning, and monitoring, leading to increased demand for diagnostic imaging devices in the EU-27 region.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.Modeling approach / Market size:
Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
